Psoriasis: The Evidence-Based Supplement Protocol

6 min read ·

Psoriasis is an immune-mediated inflammatory skin disease driven by IL-17/IL-23 pathway activation. Topical corticosteroids, topical vitamin D analogues (calcipotriol), phototherapy, methotrexate, and biologics (TNF-α, IL-17, IL-23 inhibitors) remain primary. Supplements have a modest role as adjuncts targeting the inflammatory and oxidative-stress components.

Vitamin D — Repletion to 30–50 ng/mL

Vitamin D deficiency is common in psoriasis cohorts. The hormone modulates Th17 differentiation — directly relevant to psoriasis pathogenesis. Topical vitamin D analogues (calcipotriol, calcitriol) are evidence-based topical therapy. Oral repletion in deficient adults modestly reduces PASI scores. See vitamin D piece.

EPA-Dominant Omega-3, 2–4 g Daily

A 2014 meta-analysis of 15 RCTs concluded omega-3 modestly reduced PASI scores and erythema-induration-desquamation. Effect smaller than topical or systemic therapy but additive. See omega-3 inflammation context.

Bioavailable Curcumin, 500 mg Twice Daily

Curcumin inhibits NF-κB and modulates IL-17 production. Small RCTs in psoriasis have shown PASI reductions when added to topical therapy. Use bioavailable form. See curcumin piece.

Selenium — Repletion in Deficiency Only

Psoriasis cohorts have lower mean serum selenium than controls. Repletion modestly reduces inflammation in deficient adults. Cap at 200 mcg/day; chronic high selenium has its own toxicity.

What NOT to Take

Avoid "psoriasis cleanse" formulas. Skip megadose biotin — interferes with thyroid lab assays and has no psoriasis evidence. Avoid evening primrose oil — null trial data. Don't replace biologic or methotrexate therapy with supplements alone in moderate-severe disease.

How to Run the Protocol

Topical corticosteroid + topical vitamin D analogue + emollients foundation. Phototherapy or biologic for moderate-severe disease. Test 25-OH-D and selenium. Layer omega-3 2 g + bioavailable curcumin 1 g daily. Add vitamin D and selenium to repletion. Smoking cessation and weight loss reduce psoriasis severity independent of any pharmacology. See condition page.

Sources

  1. Upala S, Yong WC, Theparee T, Sanguankeo A. "Effect of omega-3 fatty acids on disease severity in patients with psoriasis: a systematic review." International Journal of Rheumatic Diseases, 2017;20(11):1816-1822. PMID: 27943643. DOI: 10.1111/1756-185X.13013.
  2. Antiga E, Bonciolini V, Volpi W, Del Bianco E, Caproni M. "Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris." BioMed Research International, 2015;2015:283634. PMID: 26090395. DOI: 10.1155/2015/283634.
  3. Stanescu AMA, Simionescu AA, Diaconu CC. "Oral vitamin D therapy in patients with psoriasis." Nutrients, 2021;13(1):163. PMID: 33429884. DOI: 10.3390/nu13010163.
  4. Michaëlsson G, Berne B, Carlmark B, Strand A. "Selenium in whole blood and plasma is decreased in patients with moderate and severe psoriasis." Acta Dermato-Venereologica, 1989;69(1):29-34. PMID: 2563608.
  5. Menter A, Strober BE, Kaplan DH, et al. "Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics." JAAD, 2019;80(4):1029-1072. PMID: 30772097. DOI: 10.1016/j.jaad.2018.11.057.